XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/boston/2020/04/30/goldfinch-bio-adds-kyle-kuvalanka-lori-rudolph-owen-to-c-suite/60%Monthly2020-04-30 21:05
https://xconomy.com/boston/2020/04/30/intellia-therapeutics-taps-semmas-lebwohl-as-chief-medical-officer/60%Monthly2020-04-30 20:58
https://xconomy.com/national/2020/04/30/podcast-san-diego-biotech-ecosystem-genomics-precision-medicine-experts/60%Monthly2020-05-13 20:14
https://xconomy.com/san-francisco/2020/04/30/bridgebios-pipeline-expansion-continues-as-portfolios-milestones-approach/60%Monthly2020-04-30 14:11
https://xconomy.com/boston/2020/04/29/adicet-aims-to-advance-car-t-therapies-in-reverse-merger-with-restorbio/60%Monthly2020-05-29 13:27
https://xconomy.com/boston/2020/04/29/radius-health-ceo-hoeiland-steps-down-martin-named-successor/60%Monthly2020-04-29 20:27
https://xconomy.com/boston/2020/04/29/forma-therapeutics-taps-ex-seres-exec-cook-as-chief-scientific-officer/60%Monthly2020-04-29 20:25
https://xconomy.com/national/2020/04/29/supernus-makes-a-parkinsons-play-with-300m-deal-for-us-worldmeds-drugs/60%Monthly2020-05-01 22:49
https://xconomy.com/texas/2020/04/29/taysha-launches-with-30m-to-bring-gene-therapy-to-cns-disorders/60%Monthly2020-05-29 13:38
https://xconomy.com/boston/2020/04/28/amag-pharma-appoints-rainiers-myers-to-succeed-ceo-william-heiden/60%Monthly2020-04-29 19:36
https://xconomy.com/national/2020/04/28/aurinia-taps-cerecors-miller-to-succeed-retiring-chief-financial-officer/60%Monthly2020-04-29 19:40
https://xconomy.com/boston/2020/04/28/at-rome-therapeutics-kapeller-aims-to-turn-junk-into-new-drugs/60%Monthly2020-04-28 23:09
https://xconomy.com/san-francisco/2020/04/28/mirum-appoints-global-bloods-radovich-as-its-chief-operating-officer/60%Monthly2020-04-29 19:43
https://xconomy.com/san-diego/2020/04/27/neurocrine-gets-fda-nod-for-once-daily-add-on-parkinsons-pill/60%Monthly2020-04-28 01:44
https://xconomy.com/san-diego/2020/04/27/erasca-lands-200m-mega-round-to-move-cancer-programs-to-the-clinic/60%Monthly2020-04-27 23:56
https://xconomy.com/boston/2020/04/27/xilio-taps-former-tesaro-exec-martin-huber-as-chief-medical-officer/60%Monthly2020-04-27 21:12
https://xconomy.com/national/2020/04/27/agentus-vp-mark-exley-appointed-chief-scientific-officer-of-imvax/60%Monthly2020-04-27 21:08
https://xconomy.com/new-york/2020/04/27/adc-therapeutics-refiles-ipo-to-fuel-cancer-drug-filing-launch-plans/60%Monthly2020-05-15 16:13
https://xconomy.com/national/2020/04/24/bio-roundup-fast-fda-approvals-biogen-delays-orics-ipo-more/60%Monthly2020-04-24 15:45
https://xconomy.com/national/2020/04/24/drug-review-times-not-shortened-much-by-single-expedited-review-designation/60%Monthly2020-04-24 12:27
https://xconomy.com/san-francisco/2020/04/24/oric-pharma-gets-120m-in-ipo-to-advance-drug-resistant-cancer-therapies/60%Monthly2020-04-24 12:08
https://xconomy.com/san-francisco/2020/04/23/nitrome-bio-bags-38m-to-prep-parkinsons-program-for-the-clinic/60%Monthly2020-04-24 03:49
https://xconomy.com/san-francisco/2020/04/23/american-diabetes-associations-ratner-joins-virta-as-chief-medical-officer/60%Monthly2020-04-23 23:46
https://xconomy.com/san-francisco/2020/04/23/ex-bristol-myers-exec-guyer-to-join-biomarin-succeeding-baffi/60%Monthly2020-04-24 02:03
https://xconomy.com/boston/2020/04/23/affinivax-lands-120m-to-take-maps-tech-into-new-vaccine-territory/60%Monthly2020-04-23 19:15
https://xconomy.com/national/2020/04/23/life-science-a-vc-bright-spot-in-q1-but-startups-may-soon-struggle/60%Monthly2020-04-23 11:51
https://xconomy.com/boston/2020/04/22/biogen-pushes-finalized-filing-for-alzheimers-drug-to-third-quarter/60%Monthly2020-04-22 21:47
https://xconomy.com/new-york/2020/04/22/immunomedics-triple-negative-breast-cancer-drug-wins-early-fda-nod/60%Monthly2020-05-28 13:52
https://xconomy.com/seattle/2020/04/22/synthorxs-shawver-joins-silverback-therapeutics-as-new-top-exec/60%Monthly2020-04-22 04:11
https://xconomy.com/national/2020/04/22/why-2020-is-pivotal-for-microbiome-drug-rd-or-maybe-2021-given-covid-19/60%Monthly2020-04-22 04:05
https://xconomy.com/national/2020/04/21/barda-director-rick-bright-moves-to-nih-to-head-covid-19-testing-rd/60%Monthly2020-04-21 22:02
https://xconomy.com/new-york/2020/04/21/cara-therapeutics-itching-drug-scratches-off-goals-of-phase-3-test/60%Monthly2020-04-21 20:52
https://xconomy.com/boston/2020/04/21/new-covid-19-special-reports-explore-clinical-research-during-the-pandemic/60%Monthly2020-04-22 14:22
https://xconomy.com/boston/2020/04/21/war-paint-to-bone-paint-mit-spinout-aims-to-transform-regenerative-meds/60%Monthly2020-04-24 08:51
https://xconomy.com/boston/2020/04/20/ohana-bio-adds-ramiro-castro-santamaria-as-chief-medical-officer/60%Monthly2020-04-21 01:41
https://xconomy.com/san-francisco/2020/04/20/sangamo-names-amgens-d-mark-mcclung-as-chief-business-officer/60%Monthly2020-04-21 14:42
https://xconomy.com/san-francisco/2020/04/20/unlearn-adds-12m-for-digital-twins-that-accelerate-clinical-trials/60%Monthly2020-05-28 19:45
https://xconomy.com/detroit-ann-arbor/2020/04/20/rockwell-medical-president-ceo-paul-resigns-ellison-named-successor/60%Monthly2020-04-20 22:56
https://xconomy.com/new-york/2020/04/20/ptc-therapeutics-promotes-matthew-klein-eric-pauwels-to-c-suite/60%Monthly2020-04-21 15:48
https://xconomy.com/national/2020/04/20/fda-approves-incyte-drug-first-ever-for-rare-bile-duct-cancer/60%Monthly2020-04-20 16:27
https://xconomy.com/seattle/2020/04/18/seattle-genetics-gets-early-fda-nod-for-breast-cancer-combo-drug/60%Monthly2020-04-18 15:20
https://xconomy.com/national/2020/04/17/covid-19-vax-efforts-aim-to-balance-speed-efficacy-in-race-to-market/60%Monthly2020-04-17 23:44
https://xconomy.com/texas/2020/04/17/lantern-pharma-ipo-file-illuminates-plan-to-rescue-failed-cancer-drugs/60%Monthly2020-05-28 20:27
https://xconomy.com/national/2020/04/17/bio-roundup-alnylams-billions-covid-19-vaccines-moma-debuts-more/60%Monthly2020-04-17 13:44
https://xconomy.com/boston/2020/04/16/tearclear-taps-former-shire-executive-robert-dempsey-as-ceo/60%Monthly2020-04-16 16:17
https://xconomy.com/san-francisco/2020/04/16/imago-biosciences-adds-edgardo-baracchini-as-chief-business-officer/60%Monthly2020-04-16 16:11
https://xconomy.com/national/2020/04/16/neurology-at-forefront-of-fdas-complex-innovative-trial-design-pilot/60%Monthly2020-04-16 13:57
https://xconomy.com/san-francisco/2020/04/16/rdmd-lands-14m-to-expand-reach-of-rare-disease-research-platform/60%Monthly2020-04-15 22:26
https://xconomy.com/new-york/2020/04/15/urogen-makes-chief-commercial-chief-development-officer-promotions/60%Monthly2020-04-16 00:24
https://xconomy.com/new-york/2020/04/15/urogen-gets-fda-nod-for-low-grade-upper-tract-urothelial-cancer-drug/60%Monthly2020-04-15 23:19
https://xconomy.com/boston/2020/04/15/ex-regeneron-exec-graham-named-evelo-bio-chief-development-officer/60%Monthly2020-04-15 16:30
https://xconomy.com/san-francisco/2020/04/15/five-prime-therapeutics-taps-foundation-meds-thomas-civik-as-new-ceo/60%Monthly2020-04-15 15:28
https://xconomy.com/boston/2020/04/15/with-harvard-tech-and-5m-pic-therapeutics-takes-aim-at-cancer/60%Monthly2020-04-15 04:24
https://xconomy.com/boston/2020/04/14/cerevance-raises-45m-to-advance-brain-disease-research-development/60%Monthly2020-04-14 22:37
https://xconomy.com/national/2020/04/14/gsk-and-sanofi-team-up-on-covid-19-vaccine-aim-for-clinic-this-year/60%Monthly2020-04-15 04:41
https://xconomy.com/san-diego/2020/04/14/arcturus-poised-to-move-liver-drug-covid-19-vaccine-into-clinic/60%Monthly2020-04-14 11:48
https://xconomy.com/national/2020/04/14/japans-kyowa-kirin-pays-mei-pharma-100m-in-blood-cancer-drug-pact/60%Monthly2020-04-14 11:58
https://xconomy.com/europe/2020/04/13/more-trust-collaboration-in-pharma-needed-to-reap-benefits-of-data-science/60%Monthly2020-04-14 00:35
https://xconomy.com/new-york/2020/04/13/ex-celgene-exec-brownstein-named-chief-medical-officer-of-cellectis/60%Monthly2020-04-13 21:38
https://xconomy.com/boston/2020/04/13/blackstone-pays-alnylam-1b-to-grab-a-stake-in-rnai-drug-inclisiran/60%Monthly2020-04-13 19:38
https://xconomy.com/national/2020/04/10/astrazeneca-wins-first-fda-drug-nod-for-nf1-a-rare-genetic-disorder/60%Monthly2020-04-11 15:13
https://xconomy.com/national/2020/04/10/akero-heads-to-top-of-class-in-nash-genfit-says-pandemic-wont-delay-data/60%Monthly2020-04-10 16:02
https://xconomy.com/seattle/2020/04/10/adaptive-biotechnologies-names-mark-adams-chief-technical-officer/60%Monthly2020-04-10 15:25
https://xconomy.com/boston/2020/04/10/tango-therapeutics-appoints-beckman-as-chief-financial-officer/60%Monthly2020-04-10 15:19
https://xconomy.com/national/2020/04/10/biotech-roundup-gsks-ante-shakeup-at-sage-telehealths-rise-more/60%Monthly2020-04-10 13:47
https://xconomy.com/texas/2020/04/09/aravive-promotes-chief-scientific-officer-gail-mcintyre-to-ceo/60%Monthly2020-04-09 19:45
https://xconomy.com/san-francisco/2020/04/09/bolt-bio-adds-mayo-clinics-edith-perez-as-chief-medical-officer/60%Monthly2020-04-09 20:11
https://xconomy.com/national/2020/04/09/pfizer-biontech-say-mrna-covid-19-vaccine-trials-may-start-this-month/60%Monthly2020-04-09 17:47
https://xconomy.com/boston/2020/04/09/tango-adds-60m-in-crispr-hunt-for-synthetically-lethal-cancer-drugs/60%Monthly2020-04-09 23:21
https://xconomy.com/new-york/2020/04/09/investors-bet-on-next-gen-telehealth-as-covid-19-fuels-adoption/60%Monthly2020-04-09 04:07
https://xconomy.com/san-francisco/2020/04/08/gilead-heightens-inflammatory-disease-focus-with-second-genome-microbiome-deal/60%Monthly2020-04-08 23:52
https://xconomy.com/san-diego/2020/04/08/organovo-future-unclear-after-shareholders-reject-tarveda-merger/60%Monthly2020-04-08 19:24
https://xconomy.com/boston/2020/04/08/roche-pays-190m-to-start-rna-drug-alliance-with-arrakis-therapeutics/60%Monthly2020-04-08 14:04
https://xconomy.com/boston/2020/04/08/keros-therapeutics-raises-96m-in-upsized-ipo-to-fuel-clinical-tests/60%Monthly2020-04-08 19:41
https://xconomy.com/national/2020/04/08/inovio-begins-experimental-covid-19-vaccine-tests-in-healthy-volunteers/60%Monthly2020-04-08 14:31
https://xconomy.com/boston/2020/04/07/sage-restructuring-halves-staff-turns-focus-to-failed-depression-drug/60%Monthly2020-04-07 23:59
https://xconomy.com/national/2020/04/07/creating-consistent-value-in-biotech-without-diluting-stakeholders/60%Monthly2020-04-07 20:35
https://xconomy.com/europe/2020/04/07/polyneuron-adds-polyphors-debra-barker-as-chief-medical-officer/60%Monthly2020-04-07 18:40
https://xconomy.com/boston/2020/04/07/morphic-appoints-arqules-schegerin-chief-financial-operating-officer/60%Monthly2020-04-07 19:05
https://xconomy.com/raleigh-durham/2020/04/07/sherlock-bios-don-haut-joins-askbio-as-chief-business-officer/60%Monthly2020-04-07 16:05
https://xconomy.com/new-york/2020/04/07/immunomedics-taps-ipsens-harout-semerjian-as-president-and-ceo/60%Monthly2020-04-07 16:00
https://xconomy.com/boston/2020/04/07/interactive-online-xcelerating-life-sciences-boston-event-set-for-may-13/60%Monthly2020-04-07 17:02
https://xconomy.com/detroit-ann-arbor/2020/04/06/millendo-may-restructure-after-prader-willi-drug-fails-pivotal-test/60%Monthly2020-04-06 22:42
https://xconomy.com/new-york/2020/04/06/menlos-itching-drug-racks-up-two-more-trial-failures-program-ends/60%Monthly2020-04-06 21:45
https://xconomy.com/boston/2020/04/06/seres-therapeutics-taps-alkermess-von-moltke-as-chief-medical-officer/60%Monthly2020-04-06 18:50
https://xconomy.com/san-francisco/2020/04/06/gsk-vir-team-up-in-covid-19-pact-aiming-to-reach-the-clinic-in-months/60%Monthly2020-04-06 15:59
https://xconomy.com/boston/2020/04/06/xconomy-releases-coronavirus-special-report-on-containing-the-pandemic-through-innovation-investment/60%Monthly2020-04-06 12:30
https://xconomy.com/boston/2020/04/03/dynacure-adds-55m-as-rna-targeted-muscle-disorder-drug-enters-clinic/60%Monthly2020-04-04 00:36
https://xconomy.com/san-diego/2020/04/03/fate-inks-100m-deal-with-janssen-for-stem-cell-derived-cancer-therapies/60%Monthly2020-05-29 13:28
https://xconomy.com/new-york/2020/04/03/zentalis-upsizes-ipo-raising-165m-for-cancer-drug-clinical-trials/60%Monthly2020-04-03 15:28
https://xconomy.com/national/2020/04/03/bio-roundup-biotech-billions-covid-19-rd-zolgensmas-path-more/60%Monthly2020-04-03 14:18
https://xconomy.com/boston/2020/04/03/venbio-partners-bags-394m-to-back-more-medicine-making-biotechs/60%Monthly2020-04-03 12:03
https://xconomy.com/san-diego/2020/04/02/locana-adds-assembly-biosciences-mackison-as-chief-business-officer/60%Monthly2020-04-03 01:25
https://xconomy.com/national/2020/04/02/flagship-adds-1-1b-for-new-meds-more-ai-health-security/60%Monthly2020-05-28 20:27
https://xconomy.com/raleigh-durham/2020/04/02/biocryst-pharma-appoints-anthony-doyle-chief-financial-officer/60%Monthly2020-04-02 21:31
https://xconomy.com/new-york/2020/04/02/brainstorm-cell-therapeutics-names-setboun-chief-operating-officer/60%Monthly2020-04-02 21:26
https://xconomy.com/national/2020/04/02/celularity-to-test-natural-killer-cell-therapy-for-cancer-against-covid/60%Monthly2020-05-29 13:28
https://xconomy.com/boston/2020/04/02/iteos-therapeutics-adds-125m-to-advance-next-gen-immunotherapies/60%Monthly2020-04-02 12:25
https://xconomy.com/national/2020/04/02/vir-advances-antibodies-against-covid-19-ceo-leads-bios-coronavirus-outreach/60%Monthly2020-04-01 16:59
https://xconomy.com/san-diego/2020/04/01/aspen-neuro-adds-70m-to-test-parkinsons-cell-therapy-in-the-clinic/60%Monthly2020-05-29 13:27
https://xconomy.com/boston/2020/04/01/pandion-pulls-in-80m-as-ulcerative-colitis-drug-advances-in-clinic/60%Monthly2020-04-01 15:25